Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Dore
David D
DD
i3 Drug Safety, Waltham, Massachusetts (Dore, Norman, Seeger).
Norman
Heather
H
Seeger
John D
JD
D000279:Administration, Cutaneous; D003271:Contraceptive Agents, Female / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D020521:Stroke / Q000139:chemically induced*; D054556:Venous Thromboembolism / Q000139:chemically induced*
D003271:Contraceptive Agents, Female